We have studied the diagnostic value of measuring lactate dehydrogenase (LD) isoenzyme 1 in serum of 331 cases of suspected acutemyocardial infarction (AMI). At a discriminatory level of 200 U/L (Scandinavian Committee on Enzymes, recommended method for the determination of LD) LD 1 verified the diagnosis in 96% of the AMI cases and excluded it in 96% of the not-AMI cases when samples were drawn 24-72 h after onset of pain. The correlation between 24.h S-LD-1 and 16-h S-CK B activities was 0.94 in the AMI cases.
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We found that quantitation of serum LD-1 is diagnostically more reliable than the serum LD-1/LD ratio.
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All five isoenzymes of lactate dehydrogenase (LD) are represented in normal human blood, serum (S), and myocardial extracts-in myocardium with a predominance of LD-1, in serum with a predominance of LD-2.7
The average proportion of LD-1 of the total LD in human myocardium is about 0.55 when determined by scanning of tetrazolium-stained lactate-to-pyruvate isoenzyme electrophoretograms and about 0.65 by specific LD-1 determination by the pyruvate-to-lactate reaction after immunoprecipitation of all four M-containing LD isoenzymes (see below).
Adding myocardial LD isoenzymes to normal serum will increase both S-LD-1 and S-LD-2 activities, finally to a point at which S-LD-1 equals S.LD-2. By still further addition of myocardial LD, S-LD-1 will exceed S-LD-2 activity: the traditional "flip" criterion (1). Obviously, the increase of S-LD-1 may be detected before the "flip" pattern occurs. Consequently, it may be expected that quantitative determination of S-LD-1 activity will detect an acute myocardial infarction (AMI) earlier after an acute episode than the flip pattern, thus providing an increase in diagnostic sensitivity. S-LD-1 determination may also be expected to show a high diagnostic specificity in complicated cases of suspected AMI such as S-CK BB after cardiac arrest with hypoxia (2), S-macro CK (3) , or extracardial S-CK MB (4). S-LD-1 may thus provide a late verification of the diagnosis in the routine diagnostic strategy of the working group of the Scandinavian Committee on Enzymes (5). The Committee's strategy requires that the time of onset of symptoms be known and that the proposed time schedule can be followed. The relatively slow disappearance rate of LD-1 activity from serum makes it feasible to measure it in only one blood sample per day.
Consequently, we studied S-LD-1 in suspected-AMI cases in two Scandinavian hospitals, Nya Lasarettet Helsingborg (NLH) and Centralsjukhuset Kristianstad (CSK).
Materials Subjects

NLH:
The subjects here were 115 suspected-AMI patients consecutively admitted to the coronary-care unit. The Committee's diagnostic strategy (5) was followed strictly:
S-CK and S-CK B were determined in blood samples drawn about 10 and 16 h after onset of acute symptoms. From 85 of these patients a 24-h blood sample was drawn for determination of S-LD-1. For classification, S-CK isoenzyme electrophoresis was carried out in all doubtful cases. S-Aspartate aminotransferase (ASAT, EC 2.6.1.1) and S.alanine aminotransferase (ALAT, EC 2.6.1.2) were determined every morning for up to three days after admission. Samples for S-lactate dehydrogenase (LD, EC 1.1.1.27), S-LD-1 determinations, and S-LD isoenzyme electrophoresis were drawn about 16 and 24 h and one month after the suspected AMI.
CSK: The subjects here were 216 suspected-AMI patients consecutively admitted to the coronary-care unit. Samples for S-ASAT, S-ALAT, S-LD, S-LD-1 assay were drawn every morning for at least three days after admission. All enzyme determinations were carried out according to the Commit. tee's recommendations (6) .
Classification
into AM! and not-AM!. AMI was defined when chest pain was associated with a positive ASAT/ALAT pattern and (or) typical evolutionary electrocardiographic signs, supplemented by S-CK and S-CK B determinations (7). S-LD and S-LD isoenzyme assays were not used for classification.
Liquid Quality Controls in Glycerol
Human myocardium was homogenized in Tris HC1 buffer, pH 7.2 (25 #{176}C), at 4#{176}C in a Potter-Elvehjem homogenizer and centrifuged (4#{176}C, 5000 x g, 20 mm). The clear supernate was adjusted to suitable activity with buffer and stabilized by adding an equal volume of glycerol (8, 9) .
Pure human LD 5(M4) was a gift from Roche-Produkter AB, Sweden.
S-LD isoenzyme electrophoresis was carried out in 10 g/L agarose gel in 75 mmol/L barbiturate buffer, pH 8.6, at 21 V/ cm for 1 h, in cells with circulating cooled (8 #{176}C) buffer. This was followed by the usual (10) tetrazolium staining, with incubation for 30 mm at 37 #{176}C. Determination of S-LD-1 Activity S-LD.1 was specifically determined by the recommended (6) method at 37 #{176}C in sample supernates after immunoprecipitation of all M-subunit-containing LD isoenzymes with the "Isomune-LD" (Roche) reagent (11). Samples with S-LD activity exceeding 2000 U/L were diluted. The manufacturer's instructions were strictly followed: To 200 tL of serum we added 50 zL of anti-human LD M subunit antibody from goat, vortex-mixed for lOs, and incubated for 5 mm at room temperature. We then added 20 L of secondantibody suspension (from a bottle with continuous stirring), vortex-mixed for 10 s, incubated for 5 mm at room temperature, and centrifuged the suspension for 10 mm at 1000 x g. S-LD-1 activity was determined in the supernates (6), centrifugal analyzers being used for the determinations.
NLII: The Rotochem centrifugal analyzer was used. Add 10 tL of sample to 500 tL of LD reagent A (6) in transfer discs. Start with 50 j.tL of reagent B (6, pyruvate). 
Graphic Evaluation of Clinical Test Data
All clinical test data are plotted in standard histograms 
Results
Titration of Isomune immunoprecipitation
capacity with pure human LD-1 isoenzyme showed a residual LD activity of less than 0.1% at 2000 U/L, 2% at 3000 U/L, and 3% at 4000 UIL.
Day-to-day imprecision
for total S-LD, S-LD-1, and fraction S-LD-1 is given in Table 1 .
S-LD-1 in Patients with Suspected AMI
The distiibution of S-LD-1 results is shown in the histograms (Figures 1-3) . Details are given in the legends. At a The results indicate that S-LD-1 is more reliable than the 36 0. S-LD-1/S-LD ratio. In clinical practice, myocardial necrosis Ag. 4. Distributionof 2-3rd day fraction S-LD-1 (CSK) and the onset of symptoms are not always synchronized. The CPD curve shows morefluctuations than found for S-LD activities.A Therefore LD-1, which has a long biological half-life in blood discnminator at 0.35 will give a diagnosticsensitivityof 0.90and a specificityof serum, seems an especially suitable assay for the diagnosis 0.96. A discriminator at 40%S-LD-1will give a sensitivity of 0.77and a specificity of A1VH. 
